Page last updated: 2024-09-05

sorafenib and perfosfamide

sorafenib has been researched along with perfosfamide in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (perfosfamide)	Trials (perfosfamide)	Recent Studies (post-2010) (perfosfamide)
6,520	730	5,251	328	18	15

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersson, BS; Champlin, RE; Li, Y; Liu, Y; Murray, D; Popat, U; Tang, X; Valdez, BC	1

Other Studies

1 other study(ies) available for sorafenib and perfosfamide

Article	Year
Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cells. Experimental hematology, 2018, Volume: 67 Topics: Alkylating Agents; Apoptosis; Busulfan; Cell Line, Tumor; Chromatin; Cyclophosphamide; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA Damage; DNA Methylation; Drug Screening Assays, Antitumor; Drug Synergism; fms-Like Tyrosine Kinase 3; Gene Duplication; Genes, p53; Humans; Leukemia, Myeloid, Acute; Membrane Potential, Mitochondrial; Neoplasm Proteins; Oxidative Stress; Precision Medicine; Signal Transduction; Sorafenib; Transplantation Conditioning	2018

Article

Year

Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cells.

Experimental hematology, 2018, Volume: 67

Topics: Alkylating Agents; Apoptosis; Busulfan; Cell Line, Tumor; Chromatin; Cyclophosphamide; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA Damage; DNA Methylation; Drug Screening Assays, Antitumor; Drug Synergism; fms-Like Tyrosine Kinase 3; Gene Duplication; Genes, p53; Humans; Leukemia, Myeloid, Acute; Membrane Potential, Mitochondrial; Neoplasm Proteins; Oxidative Stress; Precision Medicine; Signal Transduction; Sorafenib; Transplantation Conditioning

2018